BioVaxys Technology
(OTC) BVAXF
BioVaxys Technology Financials at a Glance
Market Cap
$1.71M
Revenue (TTM)
$0.00
Net Income (TTM)
$6.04M
EPS (TTM)
$-0.16
P/E Ratio
-0.37
Dividend
$0.00
Beta (Volatility)
0.14 (Low)
Dividend
$0.00
Beta (Volatility)
0.14 (Low)
Price
$0.06
Volume
14,835
Open
$0.06
Price
$0.06
Volume
14,835
Open
$0.06
Previous Close
$0.06
Daily Range
$0.06 - $0.06
52-Week Range
$0.03 - $0.43
Dividend
$0.00
Beta (Volatility)
0.14 (Low)
Price
$0.06
Volume
14,835
Open
$0.06
Previous Close
$0.06
Daily Range
$0.06 - $0.06
52-Week Range
$0.03 - $0.43
BVAXF News
BVAXF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BioVaxys Technology
Industry
Pharmaceuticals
Sector
Health CareCEO
James Christopher Passin
Website
www.biovaxys.comHeadquarters
Etobicoke, BC V6C 1L6, CA
BVAXF Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
92%
Return on Assets
-4%
Earnings Yield
-2.70%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.71M
Shares Outstanding
29.15M
Volume
14.84K
Short Interest
0.00%
Avg. Volume
45.01K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$3.12M
EBITDA
$0.00
Operating Cash Flow
$1.86M
Capital Expenditure
$1.06M
Free Cash Flow
$2.92M
Cash & ST Invst.
$211.81K
Total Debt
$68.08K
BioVaxys Technology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$1.71M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$910.06K
+23.3%
EBITDA
$0.00
+100.0%
Quarterly Fundamentals
Net Cash
$129.64K
-131.6%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$133.72K
+64.7%
Return on Assets
-4.36%
N/A
Return on Invested Capital
92.14%
N/A
Free Cash Flow
$1.06M
-156.3%
Operating Cash Flow
$1.06M
-156.3%